DRUG · Unmapped registry intervention
BMS-986488
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
NCT06764771
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Adagrasib
Normalized identity: adagrasibView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Cetuximab
Normalized identity: cetuximabView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Nivolumab
Normalized identity: nivolumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Malignant Tumorsunresolved
Interventions
BMS-986488DRUG
AdagrasibDRUG · verified · RxNorm: adagrasib
CetuximabDRUG · verified · RxNorm: cetuximab
NivolumabDRUG · verified · RxNorm: nivolumab
Sponsors & collaborators
Bristol-Myers Squibblead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06764771 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.